NorthWest Biotherapeutics Inc (NWBO)

[austinmediainc]

Although I respect that is the way you feel, it is just that, a feeling. My biggest point of contention here is that you and others are blindly speaking as if you know it's in the best interest of shareholders when you do not. I am not insinuating that the company has done anything wrong, I simply believe the details need to be addressed. By not addressing it - it casts a shadow of doubt over everything else that is going on.

Cognate provides essential services enabling the company to continue its clinical trials, which is the fastest pathway, based on the said analysis given to the options for allocating resources, to generating revenues.

The point is, how do you know we couldn't have developed and manufactured our Dendritic Cell Immunotherapy products better on our own? Don't say it's because we didn't have the money because as I've said earlier we could be financing the whole thing plus Cognates profit for all you know! We have raised over 60 million in the last 2 years.

IMUC while fully enrolled spent $5,339,716 in 2013 on research and development. Before anyone gets their shorts in a knot, I understand the differences in the treatments but how come our 2013 research and development was 8 times that at $43,906,000 and our general and administrative expense was 2 x their R&D at $12,364,000. Does that not raise any questions in anybodies mind?? Oh ya but everyone can come out and say we are getting the best deal, in the best scenario for all shareholders.....BS.